The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
The Comparative Study on Treating Schizophrenia Patients Used in Risperidone and Ziprazidone
Author(s): 
Pages: 5-7
Year: Issue:  5
Journal: WORLD HEALTH DIGEST·MEDICAL MONTHLY

Keyword:  齐拉西酮精神分裂症;
Abstract: 目的:观察齐拉西酮治疗精神分裂症的疗效及不良反应.方法:对符合CCMD-3精神分裂症诊断标准的40例病人,以齐拉西酮120~200mg/日治疗与利培酮3~5mg/日治疗进行对照,用PANSS、TESS在治疗前和治疗后第2和6周末各评定一次.结果:40例病人利培酮组有1例因副反应脱落,其余均完成试验.齐拉西酮与利培酮疗效相当,在体重、月经改变等方面副反应比利培酮少,两者间无统计学差异.结论:齐拉西酮是安全有效的抗精神病药物.
Related Articles
No related articles found